Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The combination therapy was effective and well-tolerated, especially in young patients.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

People with alopecia areata often have lower vitamin D levels than healthy people.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

0.05% Betamethasone Dipropionate is the most effective topical treatment for alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.